Europe’s liver disease crisis has reached a point where experts now want governments to hit alcohol and junk food with much higher taxes.
A new report, according to the summary of its findings, argues that policymakers need tougher measures to confront what it calls an “escalating and unsustainable burden” of liver-related illness across the continent. The headline number gives the warning its force: 284,000 people die from liver disease in Europe each year. Experts say governments should raise taxes sharply enough to reflect the wider damage these products impose not only on hospitals, but also on social services and the criminal justice system.
The argument from experts is stark: if alcohol and unhealthy food drive a growing toll of disease and public cost, taxes should finally reflect that reality.
Key Facts
- Experts are calling for much higher taxes on alcohol and unhealthy food in Europe.
- The report links the push to 284,000 liver disease deaths each year across the continent.
- It describes liver-related harm as an “escalating and unsustainable burden.”
- Reports indicate advocates want tax revenue to cover strain on health, justice and social systems.
The proposal lands in the middle of a long-running political fight over how far governments should go to shape consumer behavior. Supporters of higher taxes often argue that price changes can reduce harmful consumption and raise money for strained public services. Critics typically warn that such measures can squeeze household budgets and trigger backlash. But this report appears to push beyond modest nudges, suggesting that incremental change no longer matches the scale of the problem.
The focus on both alcohol and unhealthy food also signals a broader view of liver disease than older debates allowed. Public discussion often narrows the issue to drinking alone, yet experts increasingly point to diet and metabolic health as part of the same emergency. That framing matters because it shifts the conversation from individual choices to the wider food and pricing environment that governments help shape through tax policy, regulation and public health strategy.
What happens next will depend on whether European governments treat this report as a warning or a mandate. Any move to raise taxes will face industry pressure and political caution, but the underlying question will not fade: who should pay for the rising cost of preventable liver disease? If officials decide the answer cannot remain with overburdened public systems, this debate could become a test case for how Europe confronts health harms tied to everyday consumption.